These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31908527)

  • 1. Serum Dickopff 1 as a Novel Biomarker in Hepatocellular Carcinoma Diagnosis and Follow Up After Ablative Therapy.
    Younis YS; Alegaily HS; Elagawy W; Semeya AA; Abo-Amer YE; El-Abgeegy M; Mostafa SM; Elsergany HF; Abd-Elsalam S
    Cancer Manag Res; 2019; 11():10555-10562. PubMed ID: 31908527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
    Mao L; Wang Y; Wang D; Han G; Fu S; Wang J
    PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
    Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W
    Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Osteopontin Level in Chronic Liver Disease and Hepatocellular Carcinoma.
    Fouad SA; Mohamed NA; Fawzy MW; Moustafa DA
    Hepat Mon; 2015 Sep; 15(9):e30753. PubMed ID: 26500684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of DKK1 and AFP improves diagnostic accuracy of hepatocellular carcinoma compared with either marker alone.
    Erdal H; Gül Utku Ö; Karatay E; Çelik B; Elbeg Ş; Doğan İ
    Turk J Gastroenterol; 2016 Jul; 27(4):375-81. PubMed ID: 27458854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of alpha-fetoprotein in detecting hepatocellular carcinoma recurrence after radiofrequency ablation.
    Siripongsakun S; Wei SH; Lin S; Chen J; Raman SS; Sayre J; Tong MJ; Lu DS
    J Gastroenterol Hepatol; 2014 Jan; 29(1):157-64. PubMed ID: 24354994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance and diagnostic value of serum dickkopf-1 in patients with hepatocellular carcinoma.
    Fouad YM; Mohamed HI; Kamal EM; Rasek MA
    Scand J Gastroenterol; 2016 Sep; 51(9):1133-7. PubMed ID: 27161933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of serum squamous cell carcinoma antigen as a novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients.
    Hussein MM; Ibrahim AA; Abdella HM; Montasser IF; Hassan MI
    Indian J Cancer; 2008; 45(4):167-72. PubMed ID: 19112206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum alpha-fetoprotein measurement in predicting clinical outcome related to autologous cytokine-induced killer cells in patients with hepatocellular carcinoma undergone minimally invasive therapy.
    Pan CC; Huang ZL; Li W; Zhao M; Zhou QM; Xia JC; Wu PH
    Chin J Cancer; 2010 Jun; 29(6):596-602. PubMed ID: 20507732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy.
    Ma WJ; Wang HY; Teng LS
    World J Surg Oncol; 2013 Aug; 11():212. PubMed ID: 23981851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.
    Choi JY; Jung SW; Kim HY; Kim M; Kim Y; Kim DG; Oh EJ
    World J Gastroenterol; 2013 Jan; 19(3):339-46. PubMed ID: 23372355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of serum midkine level in diagnosis of hepatocellular carcinoma.
    Shaheen KY; Abdel-Mageed AI; Safwat E; AlBreedy AM
    Int J Hepatol; 2015; 2015():146389. PubMed ID: 25737783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of AFP-L3 and p53 Antigen Concentration with Alpha-Fetoprotein as Serum Markers for Hepatocellular Carcinoma.
    Abdel-Aziz MM; Elshal MF; Abass AT; El-Kafrawy S; Ezzat S; Abdel-Wahab M
    Clin Lab; 2016; 62(6):1121-9. PubMed ID: 27468575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokeratin-18 in Diagnosis of HCC in Patients with Liver Cirrhosis.
    Ismail SA; El Saadany Sh; Ziada DH; Zakaria SS; Mayah WW; Elashry H; Arafa M; Elmashad N
    Asian Pac J Cancer Prev; 2017 Apr; 18(4):1105-1111. PubMed ID: 28547948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma.
    Vongsuvanh R; van der Poorten D; Iseli T; Strasser SI; McCaughan GW; George J
    PLoS One; 2016; 11(5):e0155800. PubMed ID: 27219517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dickkopf-1: as a diagnostic and prognostic serum marker for early hepatocellular carcinoma.
    Yang H; Chen GD; Fang F; Liu Z; Lau SH; Zhang JF; Lau WY; Yang LY
    Int J Biol Markers; 2013 Sep; 28(3):286-97. PubMed ID: 23568769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.
    Xiao J; Long F; Peng T; Hu LB; Cai H; Chen R; Chen WL
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3302-3310. PubMed ID: 31081083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum vascular endothelial growth factor as a tumor marker for hepatocellular carcinoma in hepatitis C virus-related cirrhotic patients.
    Alzamzamy A; Elsayed H; Abd Elraouf M; Eltoukhy H; Megahed T; Aboubakr A
    World J Gastrointest Oncol; 2021 Jun; 13(6):600-611. PubMed ID: 34163576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list.
    Fisher RA; Maluf D; Cotterell AH; Stravitz T; Wolfe L; Luketic V; Sterling R; Shiffman M; Posner M
    Clin Transplant; 2004 Oct; 18(5):502-12. PubMed ID: 15344951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum epidermal growth factor-like domain 7 serves as a novel diagnostic marker for early hepatocellular carcinoma.
    Yang MY; Wu F; Fang F; Yang H; Zhang JF; Chen GD; Yang LY
    BMC Cancer; 2021 Jul; 21(1):772. PubMed ID: 34217251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.